Staar Surgical Co

Visual Financials
Company Name: Staar Surgical Co
Ticker Symbol: STAA
CIK Number: 0000718937
WWW Address: http://www.staar.com
CEO: Caren L. Mason
No. of Employees: 336
Common Issue Type: CS
Business Description:STAAR Surgical designs, develops, manufactures and sells implantable lenses for the eye. It is a maker of lenses used worldwide in corrective or 'refractive' surgery, and it also make lenses for use in surgery that treats cataracts.

 
Industry Information: HEALTH SERVICES - Medical Instruments & Supplies [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 26.31 Unchanged 0.0 25.0 29.0  26.02 24.80 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 1,170.1 44.5 0.00 0.12 0.00 200.2 0.0 54.00 - 21.70
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close25.53$
PE Ratio - LTM200.2
Market Capitalisation1,170.1mil
Latest Shares Outstanding44.5mil
Earnings pS (EPS)0.12$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee260,956$
Effective Tax Rate0.3%
Float33.2mil
Float as % of Shares Outstanding0.7%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.50%
Research & Devlopment (R&D) as % of Revenue0.20%
Gross Profit Margin73.8%
EBITDA Margin7.3%
Pre-Tax Profit Margin0.0%
Assets Turnover105.4%
Return on Assets (ROA)4.2%
Return on Equity (ROE)5.7%
Return on Capital Invested (ROCI)5.3%
Current Ratio5.5
Leverage Ratio (Assets/Equity)1.3
Interest Cover
Total Debt/Equity (Gearing Ratio)0.04
LT Debt/Total Capital0.0%
Working Capital pS2.78$
Cash pS0.00$
Book-Value pS3.09$
Tangible Book-Value pS2.93$
Cash Flow pS0.24$
Free Cash Flow pS0.16$
KEY FIGURES (LTM): Price info
Price/Book Ratio7.99
Price/Tangible Book Ratio0.00
Price/Cash Flow104.2
Price/Free Cash Flow153.8
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---10.2451,2872,225,952
4 Weeks27.3222.8426.55-3.8397,9647,561,332
13 Weeks39.6021.7036.41-29.9463,03729,171,357
26 Weeks42.0021.7033.89-24.7431,03853,448,811
52 Weeks54.0021.7029.45-13.3463,954115,988,701
YTD42.0021.70--17.9434,93646,973,187
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
24.1524.1229.2633.4636.810.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.110.40.17
Income0.660.8
Dividend0.0
Capital Spending0.31NA
R&D-2.92NA2.95
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %16.116.11.6
Earnings %103.0103.0-100.0
EPS %0.00.0-100.0
EPS $0.000.00-0.09
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio74.01
Current Ratio5.5
Quick Ratio (Acid Test)4.7
Liquidity Ratio (Cash)7.49
Receivables Turnover5.7
Average Collection Period63
Working Capital/Equity93.5
Working Capital pS2.80
Cash-Flow pS0.28
Free Cash-Flow pS0.23
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio1.76
Financial Leverage Ratio (Assets/Equity)0.0
Debt Ratio3.2
Total Debt/Equity (Gearing Ratio)0.04
LT Debt/Equity0.00
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities0.0
Interest Cover0.0
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio6.56
Current P/E Ratio - LTM200.20
Enterprise Value (EV)/EBITDA98.28
Enterprise Value (EV)/Free Cash Flow96.39
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM7.99
Price/Cash Flow Ratio104.2
Price/Free Cash Flow Ratio - LTM153.8
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM570.0
P/E Ratio (52 weeks ago) - LTM200.5
5-Y High P/E Ratio415.4
5-Y Low P/E Ratio37.2
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E-17
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS0.00
Current Liabilities pS1.15
Tangible Book Value pS - LTM2.93
Book Value pS - LTM3.09
Capital Invested pS3.06
Cash pS - LTM0.00
Cash Flow pS - LTM0.24
Free Cash Flow pS - LTM0.16
Earnings pS (EPS)0.12
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin8.49
Free Cash Flow Margin 5YEAR AVG-2.72
Net Profit Margin0.0
Net Profit Margin - 5YEAR AVRG.-0.1
Equity Productivity0.94
Return on Equity (ROE)0.1
Return on Equity (ROE) - 5YEAR AVRG.-0.1
Capital Invested Productivity0.91
Return on Capital Invested (ROCI)-0.1
Return on Capital Invested (ROCI) - 5YEAR AVRG.-0.1
Assets Productivity1.10
Return on Assets (ROA)0.0
Return on Assets (ROA) - 5YEAR AVRG.-0.1
Gross Profit Margin73.8
Gross Profit Margin - 5YEAR AVRG.0.7
EBITDA Margin - LTM7.3
EBIT Margin - LTM5.3
Pre-Tax Profit Margin-0.1
Pre-Tax Profit Margin - 5YEAR AVRG.-0.1
Effective Tax Rate16.8
Effective Tax Rate - 5YEAR AVRG.-3.0
EFFICIENCY RATIOS
Cash Conversion Cycle
Revenue per Employee260,956
Net Income per Employee10,459
Average Collection Period
Receivables Turnover5.7
Day's Inventory Turnover Ratio
Inventory Turnover2.2
Inventory/Sales13.5
Accounts Payble/Sales5.26
Assets/Revenue0.91
Net Working Capital Turnover1.00
Fixed Assets Turnover7.86
Total Assets Turnover1.1
Revenue per $ Cash1.19
Revenue per $ Plant10.82
Revenue per $ Common Equity0.94
Revenue per $ Capital Invested0.91
Selling, General & Adm/tive (SG&A) as % of Revenue50.7
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue17.8
R&D Expense as % of Revenue - 5YEAR AVRG.17.8

  


Your Recent History
NASDAQ
STAA
Staar Surg..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.